Quantitative Gradient Echo MRI Identifies Dark Matter as a New Imaging Biomarker of Neurodegeneration that Precedes Tissue Atrophy in Early Alzheimer's Disease
Manuscript Number:
21-0503R3
Author(s):
Andrew J. Aschenbrenner, Tammie LS Benzinger, Anne M. Fagan, Manu S. Goyal, Charles F. Hildebolt, Satya V.V.N. Kothapalli, John C. Morris, Richard J. Perrin, Marcus E. Raichle, Dmitriy A. Yablonskiy
Disclosures
Andrew J. Aschenbrenner
Nothing to Disclose
Tammie LS Benzinger
Consulting Fees:
Biogen MRI advisory board, funds paid to me.
Lecture Fees:
Biogen, funds paid to me.
Anne M. Fagan
Consulting Fees:
Advisory Board membership for Roche Diagnostics, Genentech, Diadem.
Consults for DiamiR and Seimens Healthcare Diagnostics Inc